NSE seeks clarification from several companies over unusual trading activity
Several listed companies in the Indian stock market are witnessing sharp price fluctuations in their shares and unusual increases in trading volumes. To provide investors with updated information and protect their interests, the National Stock Exchange is seeking clarification from the relevant companies, while responses remain pending in some cases.
Highlights
- NSE sent letters to six companies, including ABH Healthcare Limited, Astec LifeSciences Limited and Madhur Knit Crafts Limited, over unusual price and volume activity.
- Anlon Healthcare Limited and Ashoka Metcast Limited received clarification letters on September 16, 2026 and September 15, 2026, respectively, which are available on the NSE website.
- Dr Reddy’s has been asked to clarify a media report concerning a voluntary licence for Gilead's HIV medicine; the company's response is pending.
This article was translated from the original. Read the original version by our correspondent here.
Action over unusual price and volume activity
As reported by NSE India, citing the National Stock Exchange of India, letters were sent to ABH Healthcare Limited, Astec LifeSciences Limited, Madhur Knit Crafts Limited, Maxposure Limited, Tega Industries Limited and Utssav CZ Gold Jewels Limited following recent unusual market activity. Some of these companies saw sharp gains or declines in their share prices, while others recorded a significant surge in trading volumes.The exchange said its aim is to provide the market with relevant and up-to-date company-related information so that investors' interests can be safeguarded. Responses from the concerned companies are still awaited in these cases.
In the cases of Anlon Healthcare Limited and Ashoka Metcast Limited, the exchange had already written to the companies on September 16, 2026 and September 15, 2026, respectively. Copies of these clarifications are available on the NSE website in the corporate filings and announcements section.
In the case of Tata Chemicals Limited, the exchange also wrote to the company after a significant increase in volume, and its clarification has been made available on the NSE website.
Focus on investor protection and information transparency
This action comes as the exchange uses the monitoring of unusual market activity as an important tool for investor protection. When a stock shows sharp changes in price or volume, the exchange asks companies to clarify whether there is any information that could affect investment decisions.In the same vein, Dr Reddy’s has also been asked to clarify a media report stating that the company received a voluntary licence for Gilead's once-yearly HIV prevention medicine. The exchange said it wants to verify the accuracy of the information reported in the media, and the company's response in this matter is also awaited.
We have previously reported on the process of clarification notices sent by the NSE over unusual price or volume activity. That report noted that when sharp fluctuations or sudden changes in trading activity are observed, the exchange sends letters to companies to ensure investors have access to current and relevant information—responses in some cases become available in NSE corporate filings, while some clarifications remain pending.